These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11710729)
21. [Risk assessment for human health associated to combined exposures and metabolic factors of individual susceptibility]. Testai E Epidemiol Prev; 2009; 33(3 Suppl 1):69-76. PubMed ID: 19776472 [No Abstract] [Full Text] [Related]
22. The role of individual susceptibility in cancer burden related to environmental exposure. Bartsch H; Hietanen E Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):569-77. PubMed ID: 8781385 [TBL] [Abstract][Full Text] [Related]
23. [Genetic basis of systemic sclerosis]. Yu J; Zuo YG; Sun QN Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):97-102. PubMed ID: 19317071 [TBL] [Abstract][Full Text] [Related]
24. The complex genetics of scleroderma. Ahmed SS; Tan FK; Arnett FC Am J Med; 2002 May; 112(7):584-6. PubMed ID: 12015255 [No Abstract] [Full Text] [Related]
25. Genetic polymorphism of cytochrome P450 as a biomarker of susceptibility to environmental toxicity. Hong JY; Yang CS Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):759-62. PubMed ID: 9255558 [TBL] [Abstract][Full Text] [Related]
26. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals. Nakajima T; Aoyama T Ind Health; 2000 Apr; 38(2):143-52. PubMed ID: 10812837 [TBL] [Abstract][Full Text] [Related]
27. Association of common variation in glutathione S-transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis. Palmer CN; Young V; Ho M; Doney A; Belch JJ Arthritis Rheum; 2003 Mar; 48(3):854-5. PubMed ID: 12632442 [No Abstract] [Full Text] [Related]
28. Hereditary polymorphisms of human drug metabolizing enzymes and cancer susceptibility. Gonzalez FJ Birth Defects Orig Artic Ser; 1990; 26(1):17-42. PubMed ID: 2224077 [No Abstract] [Full Text] [Related]
29. A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. Bottomley WW; Sheehan-Dare RA; Hughes P; Cunliffe WJ Br J Dermatol; 1993 Feb; 128(2):203-6. PubMed ID: 8457454 [TBL] [Abstract][Full Text] [Related]
30. Familial scleroderma: do environmental factors, genes and microchimerism share the same relevance? Del Rosso A; Pignone A; Giacomelli R; Cerinic MM J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):11-4. PubMed ID: 11451311 [No Abstract] [Full Text] [Related]
31. [Clinical significance of some genetic polymorphisms of cytochrome P-450: family CYP1 and subfamilies CYP2A, CYP2B and CYP2C]. Wojtczak A; Skretkowicz J Pol Merkur Lekarski; 2009 Mar; 26(153):248-52. PubMed ID: 19388543 [TBL] [Abstract][Full Text] [Related]
32. [Study of the molecular mechanism of human cytochrome P450 and genetic polymorphism of drug oxidative metabolizing enzyme]. Zhao L; Lou YQ Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):35-40. PubMed ID: 10921075 [TBL] [Abstract][Full Text] [Related]
33. Role of cytochrome P-450 genetic polymorphisms in oral carcinogenesis. Hernando-Rodriguez M; Rey-Barja N; Marichalar-Mendia X; Rodriguez-Tojo MJ; Acha-Sagredo A; Aguirre-Urizar JM J Oral Pathol Med; 2012 Jan; 41(1):1-8. PubMed ID: 21793938 [TBL] [Abstract][Full Text] [Related]
34. Polymorphism of CYP450 and cancer susceptibility. Han XM; Zhou HH Acta Pharmacol Sin; 2000 Aug; 21(8):673-9. PubMed ID: 11501173 [TBL] [Abstract][Full Text] [Related]
35. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524 [TBL] [Abstract][Full Text] [Related]
36. No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis. Carmona FD; Serrano-Lopera A; López-Isac E; Simeón CP; Carreira P; Rios-Fernandez R; Espinosa G; Camps MT; Navarrete N; González-Escribano MF; Vicente-Rabaneda E; Rodríguez-Rodríguez L; Tolosa C; Beltrán E; Gómez-Garcia I; Fernández-Castro M; López-Longo FJ; García-Hernández FJ; Castellví I; Trapiella L; Fernández-Nebro A; García-Portales R; Egurbide MV; Fonollosa V; García de la Peña P; Pros A; Rodríguez-Carballeira M; Díaz-Gónzalez F; Sáez-Comet L; González-Gay MA; Martín J Clin Exp Rheumatol; 2011; 29(5):895-6. PubMed ID: 22011385 [No Abstract] [Full Text] [Related]
37. [Systemic sclerosis. Part 1: searching for genetic determinants]. Midro AT; Panasiuk B; Fryc J; Stasiewicz-Jarocka B; Sierakowski S Przegl Lek; 2012; 69(9):687-93. PubMed ID: 23401990 [TBL] [Abstract][Full Text] [Related]
38. Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus. von Schmiedeberg S; Fritsche E; Rönnau AC; Specker C; Golka K; Richter-Hintz D; Schuppe HC; Lehmann P; Ruzicka T; Esser C; Abel J; Gleichmann E Adv Exp Med Biol; 1999; 455():147-52. PubMed ID: 10599336 [TBL] [Abstract][Full Text] [Related]
39. Comment on: An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Zhang Y; Pointon JJ; Wordsworth BP Rheumatology (Oxford); 2008 Apr; 47(4):556-7; author reply 557. PubMed ID: 18084000 [No Abstract] [Full Text] [Related]